Justin "Jay" Bader, MD, MHS

2026

• Expanding the Surgical Clinical Trials Workforce Through Structured Undergraduate Research Programs

  Liu S, Ospina A, Belperron A, Bader JM, Turaga K. Expanding the Surgical Clinical Trials Workforce Through Structured Undergraduate Research Programs. The American Surgeon™ 2026, 00031348261505259. DOI: 10.1177/00031348261505259.

  Peer-Reviewed Original Research

• Antiplatelet Therapy and Bleeding, Thrombosis, and Aneurysm Growth in Patients with Abdominal Aortic Aneurysms

  Crews B, Li J, Kostiuk V, Said S, Bader J, Zwibelman H, Strosberg D, Guzman RJ, Aboian E, Ochoa Chaar CI. Antiplatelet Therapy and Bleeding, Thrombosis, and Aneurysm Growth in Patients with Abdominal Aortic Aneurysms. Annals Of Vascular Surgery 2026 DOI: 10.1016/j.avsg.2026.10.016.

  Peer-Reviewed Original Research

• Real-World Survival After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer

  Ermer T, Bader JM, de Santis W, Asmelash S, Tremblay EE, Kim SY, Goldberg SB, Blasberg JD, Schalper KA, Dacic S, Woodard GA. Real-World Survival After Neoadjuvant Chemoimmunotherapy for Resectable Non-Small Cell Lung Cancer. JTO Clinical And Research Reports 2026, 101107. DOI: 10.1016/j.jtocrr.2026.101107.

  Peer-Reviewed Original Research

• Experiences and Decisional Outcomes After Cytoreductive Surgery for Peritoneal Surface Malignancy: The DECISIVE Study.

  Godfrey EL, Aguirre N, Bader J, Moses JV, Linhares SM, Hamid SA, Lindsay ME, Proussaloglou EM, Berger ER, Valero MG, Shergill A, Turaga KK, Greenup RA. Experiences and Decisional Outcomes After Cytoreductive Surgery for Peritoneal Surface Malignancy: The DECISIVE Study. Ann Surg Oncol 2026 PMID: 42778842, DOI: 10.1245/s10434-026-20449-y.

  Peer-Reviewed Original Research

• AI-powered semantic segmentation model for enhanced ureteral mapping and real-time instrument feedback in robotic colorectal surgery

  Bader J, Sun X, Rosenfelt T, Ramirez-Hardy A, Sapir N, Scheub R, Vitchutripop T, Khanna A, Pantel H, Rakita D. AI-powered semantic segmentation model for enhanced ureteral mapping and real-time instrument feedback in robotic colorectal surgery. Journal Of Robotic Surgery 2026, 20: 859. PMID: 42618847, DOI: 10.1007/s11701-026-03807-6.

  Peer-Reviewed Original Research

  MeSH Keywords

• Optimizing Safety in Robotic-Assisted Right Hepatectomy With Techniques for Complete Vascular Control of the Left and Middle Hepatic Veins: A Case Report

  Bader J, Su D, Liu S, Billingsley K. Optimizing Safety in Robotic-Assisted Right Hepatectomy With Techniques for Complete Vascular Control of the Left and Middle Hepatic Veins: A Case Report. Cureus 2026, 18: e112644. PMID: 42598298, PMCID: PMC13472603, DOI: 10.7759/cureus.112644.

  Peer-Reviewed Original Research

• Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma

  Bader J, Dhiman A, Aguirre N, Ofori K, Gupta P, Qin H, Sharma A, Mitchell O, Tjota M, Husain A, Drazer M, Churpek J, Kindler H, Turaga K. Prognostic impact of somatic mutations among patients with pleural and peritoneal mesothelioma. Npj Precision Oncology 2026, 10: 281. PMID: 42426379, PMCID: PMC13373184, DOI: 10.1038/s41698-026-01495-x.

  Peer-Reviewed Original Research

  This study investigates the prognostic impact of somatic mutations in mesothelioma, showing NF2 truncating variants worsen survival, supporting genomic testing to guide treatment strategies.

  Full Summary

• ASO Visual Abstract: Peritoneal Metastases in Stage II–III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance

  Ofori K, Smart H, Liu S, Bader J, Aguirre N, Gupta P, Sharma A, Turaga K. ASO Visual Abstract: Peritoneal Metastases in Stage II–III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance. Annals Of Surgical Oncology 2026, 33: 8567-8567. PMID: 42334717, DOI: 10.1245/s10434-026-19980-9.

  Peer-Reviewed Original Research

• Peritoneal Metastases in Stage II–III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance

  Ofori K, Smart H, Liu S, Bader J, Aguirre N, Gupta P, Sharma A, Turaga K. Peritoneal Metastases in Stage II–III Colon Cancer Represent a Blind Spot for Circulating Tumor DNA Surveillance. Annals Of Surgical Oncology 2026, 33: 8555-8558. PMID: 42265516, DOI: 10.1245/s10434-026-19903-8.

  Peer-Reviewed Original Research

  This study investigates the limitations of circulating tumor DNA (ctDNA) surveillance in stage II–III colon cancer, showing reduced detection of isolated peritoneal metastases due to biological constraints.

  Full Summary

• Increased rates of surgical resection of early-stage small cell lung cancer in a single-institution cohort

  Ely S, Bader J, Van Udelsman B, Zolfaghari E, Chiang A, de Santis W, Reginauld S, Dhanasopon A, Homer R, Cai G, Woodard G. Increased rates of surgical resection of early-stage small cell lung cancer in a single-institution cohort. Journal Of Thoracic Disease 2026, 18: 664-664. PMID: 42444860, PMCID: PMC13358850, DOI: 10.21037/jtd-2026-0460.

  Peer-Reviewed Original Research

  Citations